<DOC>
	<DOCNO>NCT02612870</DOCNO>
	<brief_summary>Patients breast cancer normally undergo label radioactive tracer typically 1 day surgery , enable surgeon localize sentinel lymph node surgery . This pilot study use magnetic Sentimag technique mark lymph node either 1 4-6 day surgery investigate concordance standard technique .</brief_summary>
	<brief_title>Sienna+® Injection Time Study 4 Arms</brief_title>
	<detailed_description>Sienna+® inject either 1 day 4-6 day surgery , either retro-mamillary peri-tumorally : - Sienna+® retro-mamillary 1 day surgery : 10 patient - Sienna+® peri-tumorally 1 day surgery : 10 patient - Sienna+® retro-mamillary 4-6 day surgery : 10 patient - Sienna+® peri-tumorally 4-6 day surgery : 10 patient In case , Technetium standard technique employ accord gold standard protocol one day surgery . The Sentimag device use surgery detect lymph node parallel standard technique .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Subject diagnosis primary breast cancer Subject schedule surgery sentinel lymph node biopsy procedure Subject ≥18 year old time consent Subject ECOG performance status Grade 02 Subject clinical negative node status Subject available followup Subject pregnant lactating Subject radiological evidence metastatic cancer Subject previous axilla surgery reduction mammoplasty Subject impair lymphatic function Subject preoperative radiation therapy Subject iron overload disease iron/dextran intolerance Subject pacemaker Subject guardianship</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Sentinel Node</keyword>
	<keyword>Sentinel Node Biopsy</keyword>
	<keyword>Breast Surgery</keyword>
</DOC>